Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Finnegan, Sorcha ^a   Robson, Joanne ^b   Scaife, Caitriona ^c   McAllister, Catherine ^d   Pennington, Stephen R ^c   Gibson, David S ^a,e   Rooney, Madeleine E ^a,d  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d MUSGRAVE PARK HOSPITAL   (United Kingdom)

^e ALTNAGELVIN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

CHILD; CLUSTER ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE RHEUMATOID ARTHRITIS; MALE; MASS SPECTROMETRY; METABOLISM; SYNOVIUM; WESTERN BLOTTING;

ARTHRITIS, JUVENILE; BLOTTING, WESTERN; CHILD; CLUSTER ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SYNOVIAL MEMBRANE;

EID: 84892402100     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4434     Document Type: Article

References (41)

1. Symmons DP, Jones M, Osborne J, Sills J, Southwood TR, Woo P. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996, 23:1975-1980.
2. Prakken BJ, Albani S. Using biology of disease to understand and guide therapy of JIA. Best Pract Res Clin Rheumatol 2009, 23:599-608. 10.1016/j.berh.2009.07.003, 19853826.
3. Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, Zink A. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:2392-2401. 10.1002/art.10444, 12355487.
4. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31:390-392. International League of Associations for Rheumatology.
5. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998, 25:1991-1994.
6. Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum 1975, 18:251-255. 10.1002/art.1780180309, 1137612.
7. Hui-Yuen JS, Imundo LF. A review guide to oligoarticular and polyarticular juvenile idiopathic arthritis. Pediatr Ann 2012, 41:1-8.
8. Gattorno M, Gregorio A, Ferlito F, Gerloni V, Parafioriti A, Felici E, Sala E, Gambini C, Picco P, Martini A. Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis. Rheumatology (Oxford) 2004, 43:1091-1096. 10.1093/rheumatology/keh250, 15199218.
9. Gregorio A, Gambini C, Gerloni V, Parafioriti A, Sormani MP, Gregorio S, De Marco G, Rossi F, Martini A, Gattorno M. Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Rheumatology (Oxford) 2007, 46:308-313.
10. Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium. Scand J Rheumatol 2008, 37:401-409. 10.1080/03009740802120010, 18830904.
11. Walker JG, Ahern MJ, Coleman M, Weedon H, Papangelis V, Beroukas D, Roberts-Thomson PJ, Smith MD. Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment. Ann Rheum Dis 2006, 65:1558-1564. 10.1136/ard.2005.050385, 1798468, 16760256.
12. Koski JM, Helle M. Ultrasound guided synovial biopsy using portal and forceps. Ann Rheum Dis 2005, 64:926-929. 10.1136/ard.2004.027409, 1755510, 15550535.
13. Gibson DS, Blelock S, Curry J, Finnegan S, Healy A, Scaife C, McAllister C, Pennington S, Dunn M, Rooney M. Comparative analysis of synovial fluid and plasma proteomes in juvenile arthritis-proteomic patterns of joint inflammation in early stage disease. J Proteomics 2009, 72:656-676. 10.1016/j.jprot.2009.01.022, 19367684.
14. Gibson DS, Finnegan S, Jordan G, Scaife C, Brockbank S, Curry J, McAllister C, Pennington S, Dunn M, Rooney ME. Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis. J Proteome Res 2009, 8:5601-5609. 10.1021/pr900680w, 19848415.
15. Caraux G, Pinloche S. PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 2005, 21:1280-1281. http://www.atgc-montpellier.fr/permutmatrix/, 10.1093/bioinformatics/bti141, 15546938.
16. Finnegan S, Clarke S, Gibson D, McAllister C, Rooney M. Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups. Ann Rheum Dis 2011, 70:1842-1850. 10.1136/ard.2010.148635, 21685110.
17. Yan X, Zhao Y, Pan J, Fang K, Wang Y, Li Z, Chang X. Vitamin D-binding protein (group-specific component) has decreased expression in rheumatoid arthritis. Clin Exp Rheumatol 2012, 30:525-533.
18. Sun S, Fang K, Zhao Y, Yan X, Chang X. Increased expression of alpha 1-anti-trypsin in the synovial tissues of patients with ankylosing spondylitis. Clin Exp Rheumatol 2012, 30:39-44.
19. Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K, Nishioka K, Saito T, Kato T. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 2006, 8:R175. 10.1186/ar2085, 1794520, 17125526.
20. Ling XB, Park JL, Carroll T, Nguyen KD, Lau K, Macaubas C, Chen E, Lee T, Sandborg C, Milojevic D, Kanegaye JT, Gao S, Burns J, Schilling J, Mellins ED. Plasma profiles in active systemic juvenile idiopathic arthritis: biomarkers and biological implications. Proteomics 2010, 10:4415-4430. 10.1002/pmic.201000298, 3517169, 21136595.
21. Rosenkranz ME, Wilson DC, Marinov AD, Decewicz A, Grof-Tisza P, Kirchner D, Giles B, Reynolds PR, Liebman MN, Kolli VS, Thompson SD, Hirsch R. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010, 62:1813-1823. 2918379, 20222116.
22. Gibson DS, Blelock S, Brockbank S, Curry J, Healy A, McAllister C, Rooney ME. Proteomic analysis of recurrent joint inflammation in juvenile idiopathic arthritis. J Proteome Res 2006, 5:1988-1995. 10.1021/pr060129t, 16889421.
23. Gibson DS, Newell K, Evans AN, Finnegan S, Manning G, Scaife C, McAllister C, Pennington SR, Duncan MW, Moore TL, Rooney ME. Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. J Proteomics 2012, 75:5479-5492. 10.1016/j.jprot.2012.06.024, 3443749, 22771520.
24. Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Complete localization of the intrachain disulphide bonds and the N-glycosylation points in the alpha-subunit of human platelet glycoprotein IIb. Biochem J 1989, 261:561-568. 1138861, 2775232.
25. Calvete JJ. On the structure and function of platelet integrin alpha IIb beta 3, the fibrinogen receptor. Proc Soc Exp Biol Med 1995, 208:346-360. 10.3181/00379727-208-43863A, 7535429.
26. Korkusuz P, Dagdeviren A, Eksioglu F, Ors U. Immunohistological analysis of normal and osteoarthritic human synovial tissue. Bull Hosp Jt Dis 2005, 63:63-69.
27. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood 2009, 113:2878-2887. 10.1182/blood-2008-06-165845, 19008457.
28. Iba T, Kidokoro A, Fukunaga M, Sugiyama K, Sawada T, Kato H. Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers. Shock 2005, 23:25-29. 10.1097/01.shk.0000144422.32647.b6, 15614127.
29. Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis. Clin Exp Rheumatol 1998, 16:533-540.
30. Robson SC, Shephard EG, Kirsch RE. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 1994, 86:322-326.
31. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011, 7:391-398. 10.1038/nrrheum.2011.76, 21647203.
32. Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003, 1:231-238. 10.1046/j.1538-7836.2003.00063.x, 12871494.
33. Gilliam BE, Reed MR, Chauhan AK, Dehlendorf AB, Moore TL. Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2011, 9:8. 10.1186/1546-0096-9-8, 3071779, 21439056.
34. Quirke AM, Fisher BA, Kinloch AJ, Venables PJ. Citrullination of autoantigens: upstream of TNFα in the pathogenesis of rheumatoid arthritis. FEBS Lett 2011, 585:3681-3688. 10.1016/j.febslet.2011.06.006, 21704035.
35. Bathon JM, Hwang JJ, Shin LH, Precht PA, Towns MC, Horton WE. Type VI collagen-specific messenger RNA is expressed constitutively by cultured human synovial fibroblasts and is suppressed by interleukin-1. Arthritis Rheum 1994, 37:1350-1356. 10.1002/art.1780370913, 7945500.
36. Alexopoulos LG, Youn I, Bonaldo P, Guilak F. Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix. Arthritis Rheum 2009, 60:771-779. 10.1002/art.24293, 2724839, 19248115.
37. Aidinis V, Carninci P, Armaka M, Witke W, Harokopos V, Pavelka N, Koczan D, Argyropoulos C, Thwin MM, Möller S, Waki K, Gopalakrishnakone P, Ricciardi-Castagnoli P, Thiesen HJ, Hayashizaki Y, Kollias G. Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis. PLoS Genet 2005, 1:e48. 10.1371/journal.pgen.0010048, 1270006, 16254600.
38. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005, 38:1543-1552. 10.1016/j.freeradbiomed.2005.02.026, 15917183.
39. Szabó-Taylor K, Eggleton P, Turner CA, Faro ML, Tarr JM, Tóth S, Whiteman M, Haigh RC, Littlechild JA, Winyard PG. Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes. Int J Biochem Cell Biol 2012, 44:1223-1231. 10.1016/j.biocel.2012.04.016, 3425769, 22565169.
40. Karasawa R, Ozaki S, Nishioka K, Kato T. Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases. Microbiol Immunol 2005, 49:57-65. 10.1111/j.1348-0421.2005.tb03640.x, 15665454.
41. Gerlag DM, Borges E, Tak PP, Ellerby HM, Bredesen DE, Pasqualini R, Ruoslahti E, Firestein GS. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res 2001, 3:357-361. 10.1186/ar327, 64846, 11714389.